SOLVAY PHARMA has a total of 15 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are VIVACQUA MARCELO, NEUTRON ROW and FIDES LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | France | 2 | |
#5 | Brazil | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hungary | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Christen Marie-Odile | 13 |
#2 | Duc Huynh | 6 |
#3 | Huizinga Jan | 6 |
#4 | Maugard Joelle | 6 |
#5 | Rat Patrice | 5 |
#6 | Blennerhasset Michael G | 5 |
#7 | Warnet Jean-Michel | 4 |
#8 | Guillaud Martial | 4 |
#9 | Macaulay Calum | 4 |
#10 | Gazdar Adi | 4 |
Publication | Filing date | Title |
---|---|---|
WO03068219A1 | Use of anethole dithiolethione in lung cancer chemoprevention | |
FR2807944A1 | USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY | |
FR2748206A1 | USE OF PINAVERIUM BROMIDE FOR THE PREVENTION OF PROLIFERATIVE PHENOMENA OF HEPATODIGESTIVE TRACT CELLS AND THE DISEASES THEREOF |